Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
l-DOPA is currently the standard treatment for alleviating the motor symptoms in Parkinson's disease. The therapeutic efficacy, however, diminishes as the disease progresses. It has been suggested that the beneficial effect of l-DOPA could be reestablished by changing the mode of administration...
Main Authors: | Erik Cederfjäll, Gurdal Sahin, Deniz Kirik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-11-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996111003494 |
Similar Items
-
Comparative analysis of Anopheles gambiae L-tyrosine decarboxylase and L-DOPA decarboxylase
by: Aljabri, Hareb Mohammed
Published: (2014) -
Two-step production of monoamines in monoenzymatic cells in the spinal cord: a different control strategy of neurotransmitter supply?
by: Mengliang Zhang
Published: (2016-01-01) -
TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect
by: Cong Zheng, et al.
Published: (2018-11-01) -
The L-DOPA/Dopamine Pathway Transgenerationally Regulates Cuticular Melanization in the Pea Aphid Acyrthosiphon pisum
by: Yi Zhang, et al.
Published: (2020-05-01) -
Plant aromatic amino acid decarboxylases: Evolutionary divergence, physiological function, structure function relationships and biochemical properties
by: Spence, Michael Patrick
Published: (2014)